Vials of HIV and Malaria test kits produced in Nigeria, highlighting local healthcare solutions.
In response to reduced US aid, Nigerian firm Codix Bio Ltd. is stepping up to locally produce millions of HIV and malaria test kits. With a new plant outside Lagos, built in collaboration with South Korea’s SD Biosensor and backed by the WHO, Codix aims to meet national demand and potentially serve the broader West and sub-Saharan Africa region. The plant’s initial capacity is 147 million kits annually, scalable to 160 million. As Nigeria faces the world’s highest malaria burden and ranks fourth globally for HIV cases, this initiative offers a critical lifeline. Codix plans to supply both the Nigerian government and global health donors like the Global Fund.
TimesLive